BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Psychiatry. Dec 19, 2026; 16(12): 123157
Published online Dec 19, 2026. doi: 10.5498/wjp.123157
Anxiety and depression comorbidity in women after first in vitro fertilization-embryo transfer failure: Prevalence and influencing factors
Qian-Jiang Zha, Zhi-Yun Chen, Yan Ji, Kang Chen
Qian-Jiang Zha, Zhi-Yun Chen, Yan Ji, Department of Reproductive Medicine Center, Huizhou Central People’s Hospital, Huizhou 516001, Guangdong Province, China
Kang Chen, Department of Psychiatric Clinic, Huizhou Central People’s Hospital, Huizhou 516001, Guangdong Province, China
Author contributions: Zha QJ, conceptualization, data curation, formal analysis, investigation, methodology, validation, visualization, writing-original draft, and writing-review and editing; Chen ZY, data curation, formal analysis, investigation, software, validation, visualization, and writing-review and editing; Ji Y and Chen K, conceptualization, methodology, project administration, validation, and writing-review and editing.
AI contribution statement: No AI tools were used.
Institutional review board statement: This study was approved by the Ethics Committee of Huizhou Central People’s Hospital, No. ky112026034.
Informed consent statement: All study participants or their legal guardian provided informed written consent about personal and medical data collection prior to study enrolment.
Conflict-of-interest statement: The authors declare no conflict of interest.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Data sharing statement: The datasets generated and/or analyzed in the current study are available from the corresponding author upon reasonable request.
Corresponding author: Qian-Jiang Zha, Associate Chief Physician, Department of Reproductive Medicine Center, Huizhou Central People’s Hospital, No. 41 Eling North Road, Huizhou 516001, Guangdong Province, China. zhaqj2024@163.com
Received: June 23, 2026
Revised: July 23, 2026
Accepted: August 5, 2026
Published online: December 19, 2026
Processing time: 149 Days and 3.3 Hours
Abstract
BACKGROUND

Infertility affects 15% of couples globally. Assisted reproductive technology has made in vitro fertilization-embryo transfer (IVF-ET) an important treatment modality for these couples. Unfortunately, first IVF-ET fails in 50%-60% of patients, triggering psychological crises. However, the mental health of women at this critical juncture remains understudied.

AIM

To assess the prevalence of anxiety and depression and their associated factors in women who have experienced the first IVF-ET failure.

METHODS

This observational study enrolled 356 women who experienced their first IVF-ET failure between March 2022 and March 2025. Within one week of receiving negative pregnancy test results, the participants completed the Self-Rating Anxiety Scale (SAS), Self-Rating Depression Scale (SDS), Multidimensional Scale of Perceived Social Support, and Family Adaptation Partnership Growth Affection Resolve Scale. Multiple linear regression was used to identify the factors independently associated with anxiety and depression.

RESULTS

The prevalence of anxiety and depression was 45.51% and 57.30%, respectively. Among the 257 participants who had either anxiety or depression, the comorbidity rate (i.e., having both conditions) was 42.41% (109/257); in the full sample, the comorbidity rate was 30.62% (109/356) (r = 0.764). For anxiety, risk factors were age (β = 0.198), infertility duration (β = 0.609), and SDS score (β = 0.749); lower scores were associated with social support (β = -0.334) and family care (β = -0.616) (R² = 0.945). SAS score (β = 0.665), social support (β = 0.383), and family care (β = 1.142) were significantly associated with depression (R² = 0.869). SAS score was strongly correlated with drug dosage (r = 0.807) and cost (r = 0.598).

CONCLUSION

First IVF-ET failure is associated with a high prevalence of anxiety and depression and with comorbidity. Age, infertility duration, and social and family support should be screened early to identify risk for anxiety and depression.

Keywords: First in vitro fertilization-embryo transfer; Anxiety; Depression; Influencing factors; Social support; Family care

Core Tip: This study focused on women who have experienced their first in vitro fertilization-embryo transfer failure, susceptible to an acute psychological crisis. It revealed high anxiety-depression comorbidity with bidirectional prediction (novel correlations with clinical parameters (drug dosage, r = 0.807; cost, r = 0.598) and identification of modifiable protective factors (social and family support) provide evidence for developing targeted screening and early interventions.

Write to the Help Desk